These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 27646333)

  • 1. Intravitreal ranibizumab for retinal arterial macroaneurysm: long-term results of a prospective study.
    Chatziralli I; Maniatea A; Koubouni K; Parikakis E; Mitropoulos P
    Eur J Ophthalmol; 2017 Mar; 27(2):215-219. PubMed ID: 27646333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravitreal Ranibizumab for the Treatment of Irvine-Gass Syndrome.
    Mitropoulos PG; Chatziralli IP; Peponis VG; Drakos E; Parikakis EA
    Ocul Immunol Inflamm; 2015 Jun; 23(3):225-31. PubMed ID: 24678790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravitreal ranibizumab or conbercept for retinal arterial macroaneurysm: a case series.
    Lin Z; Hu Q; Wu Y; Xu J; Zhang Q
    BMC Ophthalmol; 2019 Jan; 19(1):18. PubMed ID: 30646868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravitreal ranibizumab (Lucentis) for branch retinal vein occlusion-induced macular edema: nine-month results of a prospective study.
    Rouvas A; Petrou P; Ntouraki A; Douvali M; Ladas I; Vergados I
    Retina; 2010 Jun; 30(6):893-902. PubMed ID: 20531142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravitreal bevacizumab for symptomatic retinal arterial macroaneurysm.
    Cho HJ; Rhee TK; Kim HS; Han JI; Lee DW; Cho SW; Kim JW
    Am J Ophthalmol; 2013 May; 155(5):898-904. PubMed ID: 23385203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravitreal bevacizumab for macular complications from retinal arterial macroaneurysms.
    Pichi F; Morara M; Torrazza C; Manzi G; Alkabes M; Balducci N; Vitale L; Lembo A; Ciardella AP; Nucci P
    Am J Ophthalmol; 2013 Feb; 155(2):287-294.e1. PubMed ID: 23111179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravitreal ranibizumab for the treatment of inflammatory choroidal neovascularization.
    Rouvas A; Petrou P; Douvali M; Ntouraki A; Vergados I; Georgalas I; Markomichelakis N
    Retina; 2011 May; 31(5):871-9. PubMed ID: 21358461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose (2.0 mg) intravitreal ranibizumab for recalcitrant radiation retinopathy.
    Finger PT; Chin KJ
    Eur J Ophthalmol; 2013; 23(6):850-6. PubMed ID: 23813109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between ranibizumab and aflibercept for macular edema associated with central retinal vein occlusion.
    Saishin Y; Ito Y; Fujikawa M; Sawada T; Ohji M
    Jpn J Ophthalmol; 2017 Jan; 61(1):67-73. PubMed ID: 27660163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ranibizumab for macular edema due to retinal vein occlusions: long-term follow-up in the HORIZON trial.
    Heier JS; Campochiaro PA; Yau L; Li Z; Saroj N; Rubio RG; Lai P
    Ophthalmology; 2012 Apr; 119(4):802-9. PubMed ID: 22301066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravitreal ranibizumab in retinal macroaneurysm.
    Wenkstern AR; Petersen H
    Graefes Arch Clin Exp Ophthalmol; 2010 Nov; 248(11):1667-70. PubMed ID: 20508944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of efficacy of intravitreal ranibizumab between non-vitrectomized and vitrectomized eyes with diabetic macular edema.
    Chen YY; Chen PY; Chen FT; Chen YJ; Wang JK
    Int Ophthalmol; 2018 Feb; 38(1):293-299. PubMed ID: 28176171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicenter, 12-month randomized study comparing dexamethasone intravitreal implant with ranibizumab in patients with diabetic macular edema.
    Callanan DG; Loewenstein A; Patel SS; Massin P; Corcóstegui B; Li XY; Jiao J; Hashad Y; Whitcup SM
    Graefes Arch Clin Exp Ophthalmol; 2017 Mar; 255(3):463-473. PubMed ID: 27632215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ranibizumab treatment for choroidal neovascularization secondary to causes other than age-related macular degeneration with good baseline visual acuity.
    Erol MK; Ozdemir O; Coban DT; Ceran BB; Bulut M
    Semin Ophthalmol; 2014 Mar; 29(2):108-13. PubMed ID: 24409939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravitreal ranibizumab for the treatment of cystoid macular edema in Irvine-Gass syndrome.
    Demirel S; Batioğlu F; Özmert E
    J Ocul Pharmacol Ther; 2012 Dec; 28(6):636-9. PubMed ID: 22731243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized controlled trial of intravitreal ranibizumab versus standard grid laser for macular edema following branch retinal vein occlusion.
    Tan MH; McAllister IL; Gillies ME; Verma N; Banerjee G; Smithies LA; Wong WL; Wong TY
    Am J Ophthalmol; 2014 Jan; 157(1):237-247.e1. PubMed ID: 24112635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
    Ding X; Li J; Hu X; Yu S; Pan J; Tang S
    Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term results of intravitreal ranibizumab for the treatment of retinal angiomatous proliferation and utility of an advanced RPE analysis performed using spectral-domain optical coherence tomography.
    Inoue M; Arakawa A; Yamane S; Kadonosono K
    Br J Ophthalmol; 2014 Jul; 98(7):956-60. PubMed ID: 24599418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal ranibizumab for macular oedema secondary to retinal vein occlusion: a retrospective study of 34 eyes.
    Puche N; Glacet A; Mimoun G; Zourdani A; Coscas G; Soubrane G
    Acta Ophthalmol; 2012 Jun; 90(4):357-61. PubMed ID: 20602625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individualized Ranibizumab Regimen Driven by Stabilization Criteria for Central Retinal Vein Occlusion: Twelve-Month Results of the CRYSTAL Study.
    Larsen M; Waldstein SM; Boscia F; Gerding H; Monés J; Tadayoni R; Priglinger S; Wenzel A; Barnes E; Pilz S; Stubbings W; Pearce I;
    Ophthalmology; 2016 May; 123(5):1101-11. PubMed ID: 26896124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.